The enzymatic activity of the extracts and compounds studied by molecular docking show a favorable inhibition on cholinesterase enzymes, especially in AChE, which demonstrates a potential benefit in alternative therapies and/or adjuvants for the treatment of neurodegenerative diseases such as Alzheimer’s disease. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.